HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch
Section

Negotiations

PBM contracts, formulary dynamics, and the terms that matter

Pharma Hub Transitions: What AssistRx’s 50% Conversion Figure Reveals About an Industry in Flux
Negotiations
Pharma Hub Transitions: What AssistRx’s 50% Conversion Figure Reveals About an Industry in Flux
AssistRx says half of its 2025 patient support programs came via hub transitions, underscoring deep vendor con…
Apr 17, 2026
PBMs’ 2026 Formulary Lists Show Rebate Model Under Pressure
NegotiationsBriefing
PBMs’ 2026 Formulary Lists Show Rebate Model Under Pressure
The 2026 exclusion lists from Caremark, Express Scripts, and Optum Rx favor private-label biosimilars and lowe…
Apr 17, 2026
Bill would force payers to apply DTC drug purchases to patient deductibles
NegotiationsFiercePharma ↗
Bill would force payers to apply DTC drug purchases to patient deductibles
A prominent physician voice in the House of Representatives has introduced a new bill that would compel insure…
Apr 17, 2026
The Net Pricing Revolution in the Drug Channel: What’s Deflating the Gross-to-Net Bubble (rerun)
NegotiationsDrug Channels ↗
The Net Pricing Revolution in the Drug Channel: What’s Deflating the Gross-to-Net Bubble (rerun)
This week, I’m rerunning some popular posts while we prepare for today’s live video webinar: PBM Industry Upda…
Apr 10, 2026
List Price Reductions Will Deflate the Gross-to-Net Bubble–and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun)
NegotiationsDrug Channels ↗
List Price Reductions Will Deflate the Gross-to-Net Bubble–and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun)
This week, I’m rerunning some popular posts while we prepare for Friday’s live video webinar: PBM Industry Upd…
Apr 8, 2026
← Newer Page 2
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.